Home
>
National Drug Code (NDC)
>
Brevicon
Brevicon - 52544-254-28 - (Norethindrone and ethinyl estradiol)
Drug Information of Brevicon
| Product NDC: | 52544-254 |
| Proprietary Name: | Brevicon |
| Non Proprietary Name: | Norethindrone and ethinyl estradiol |
| Active Ingredient(s): | & nbsp; Norethindrone and ethinyl estradiol |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Brevicon
| Product NDC: | 52544-254 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017743 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19760329 |
Package Information of Brevicon
| Package NDC: | 52544-254-28 |
| Package Description: | 3 BLISTER PACK in 1 CARTON (52544-254-28) > 1 KIT in 1 BLISTER PACK |
NDC Information of Brevicon
| NDC Code | 52544-254-28 |
| Proprietary Name | Brevicon |
| Package Description | 3 BLISTER PACK in 1 CARTON (52544-254-28) > 1 KIT in 1 BLISTER PACK |
| Product NDC | 52544-254 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Norethindrone and ethinyl estradiol |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 19760329 |
| Marketing Category Name | NDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
